ULTRAGENYX EUROPE GMBH
502078-5456ActiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Overview
- 1–4
- Employees
- Unknown
- Revenue
- 2022
- Founded
Key Decision Makers
Emil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Description
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Utländsk juridisk person
- VAT Number
- SE502078545601
Decision Makers
2 contacts in FunnelfeedrEmil D. Kakkis
Chief Executive Officer and President
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer and President
Similar Companies
20 similar companies in FunnelfeedrBridgeBio International GmbH
1–4 employeesDeveloping transformative medicines for rare genetic conditions quickly.
SAREPTA THERAPEUTICS, INC.
0 employeesEngineering precision genetic medicine to rescue lives from rare diseases.
OxThera Intellectual Property AB
0 employeesDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Orchard Therapeutics (Sweden) AB
1–4 employeesDeveloping life-transforming HSC gene therapies for severe genetic diseases.
AMICUS THERAPEUTICS LTD
1–4 employeesGlobal biotechnology company developing transformative medicines for rare diseases.
Browse More
ULTRAGENYX EUROPE GMBH Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo